Evidence map›Paper›PMID 20556396›Full record

ArticleInternational journal of colorectal disease2010

Effect of beta blocker combined with COX-2 inhibitor on colonic anastomosis in rats.

Barak Benjamin, Ofir Hazut, Lee Shaashua, Marganit Benish, Niv Zmora, Iris Barshack, Aviad Hoffman, Shamgar Ben-Eliyahu, Oded Zmora

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of colorectal disease, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. The effect of bevacizumab on colon anastomotic healing in rats.International journal of colorectal disease · 2010
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Barak BenjaminDepartment of Surgery, Meir Medical Center, Tel Aviv, Israel.
Ofir Hazut
Lee Shaashua
Marganit Benish
Niv Zmora
Iris Barshack
Aviad Hoffman
Shamgar Ben-Eliyahu
Oded Zmora
Sheba Medical Center · ILTel Aviv University · ILMeir Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePharmacologic modulation of the perioperative physiologic stress response, using the beta-blocker propranolol, combined with the COX-2 inhibitor etodolac, has been shown to reduce metastatic spread and increase survival rates following surgery for primary tumor excision in rodents. Prior to implantation of this pharmacological approach in clinical trials in patients with colon cancer, the safety of this technique has to be evaluated. This study assessed the effects of these drugs on the healing of colonic anastomosis in rats.

methodsForty-eight F344 rats were divided into two groups, which were given seven daily subcutaneous injections of either vehicle, or propranolol (up to 1.2 mg/kg/day) combined with etodolac (12.5 mg/kg/day), starting the day before surgery. Each animal underwent laparotomy, colotomy of the descending colon, and anastomosis. Anastomotic leak rate and bursting pressure were compared at 1 week after the operation. The harvested anastomosis was histologically assessed for wound healing parameters.

resultsForty-three rats survived the operation and were eligible for analysis at 1 week. No significant difference in survival, anastomotic leakage, or bursting pressure was found between animals that received propranolol and etodolac versus those receiving vehicle (drugs 179 mmHg ± 45.4; vehicle 187 mmHg, SD ± 35.0, p = 0.54). Histologic assessment of fibrosis, necrosis, cell infiltration, and tissue reaction zone did not differ between the two groups.

conclusionsPerioperative administration of propranolol and etodolac seems safe in colon operations in rats and does not affect anastomotic failure or colon healing.

Indexed as

Adrenergic beta-AntagonistsAnastomosis, SurgicalAnastomotic LeakAnimalsColonCyclooxygenase 2 InhibitorsDigestive System Surgical ProceduresDrug Therapy, CombinationEtodolacLaparotomyPressurePropranololRatsRats, Inbred F344Wound HealingAdrenergic beta-AntagonistsCyclooxygenase 2 InhibitorsEtodolacPropranolol

Identifiers

PMID20556396
OpenAlexW2047606781

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.